tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katie Tryhane, 8 are a BUY (80%), 2 are a SELL (20%).
Analyst Katie Tryhane, carries an average stock price target met ratio of 64.29% that have a potential upside of 14.19% achieved within 288 days.
Katie Tryhane’s has documented 20 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Aug-2022.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGS ) at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
27 days ago
(17-Nov-2025)
5/7 (71.43%)
$27.87 (10.63%)
136
Buy
$197
$18.86 (10.59%)
$105
1 months 4 days ago
(10-Nov-2025)
7/9 (77.78%)
$28.03 (16.59%)
98
Buy
$210
$31.86 (17.88%)
$195
1 months 8 days ago
(06-Nov-2025)
7/8 (87.5%)
$42.3 (25.22%)
50
Hold
$199
$20.86 (11.71%)
$140
1 months 8 days ago
(06-Nov-2025)
14/18 (77.78%)
$31.3 (18.66%)
60
Hold
$174
$-4.14 (-2.32%)
$155
1 months 27 days ago
(17-Oct-2025)
5/5 (100%)
$-4.52 (-2.53%)
52
What Year was the first public recommendation made by Katie Tryhane?
